2013
DOI: 10.1016/j.clbc.2012.09.019
|View full text |Cite
|
Sign up to set email alerts
|

Association of the Arg194Trp and the Arg399Gln Polymorphisms of the XRCC1 Gene With Risk Occurrence and the Response to Adjuvant Therapy Among Polish Women With Breast Cancer

Abstract: We suggest that the polymorphism of the XRCC1 gene may be considered a predictive factor associated with the risk of occurrence and the survival outcome in breast cancer among Polish women.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
20
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 55 publications
2
20
1
Order By: Relevance
“…The selection of these functional polymorphisms was based on their wide evaluation in association with various forms of cancer [9][15].…”
Section: Methodsmentioning
confidence: 99%
“…The selection of these functional polymorphisms was based on their wide evaluation in association with various forms of cancer [9][15].…”
Section: Methodsmentioning
confidence: 99%
“…Numerous mutations in XRCC1 have been reported to interrupt the protein function by altering binding sites or catalytic domain of the protein (Caldecott, 2003). The 194Trp codon of XRCC1 is located in a highly conserved hydrophobic linker region between its DNA polymerase β domain and poly (ADP-ribose) polymerase-interacting domains, so the change from arginine to tryptophan could alter theinteraction of XRCC1 with either or both of these DNA repair proteins within the base excision repair complex (Przybylowska-Sygut et al, (2013). The Arg399Gln polymorphism alters Arginine to Glutamine substitution at codon 399 of exon 10 (C>T, rs25487) and is located in the conserved residue of the poly (ADP-ribose) polymerase-binding domain of XRCC1 (Pramanik et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Despite many studies showed no association between breast cancer and XRCC1 gene polymorphisms (Thyagarajan et al, 2006;Smith et al, 2008;Liu et al, 2011b), some demonstrated increase in risk of breast cancer (Przybylowska-Sygut et al, 2013a;Shadrina et al, 2014b) or even decrease of breast cancer risk (Patel et al, 2005a).…”
mentioning
confidence: 99%